Pharmaceutical Gelatin Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Pharmaceutical Gelatin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Type A, Type B), By Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry), By Function (Stabilizing, Thickening, Gelling, Others), By End User (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat, Others), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The Global Pharmaceutical Gelatin Market is projected to expand from USD 2.12 Billion in 2025 to USD 3.03 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 6.13%. This high-molecular-weight biopolymer, derived from the partial hydrolysis of collagen, is crucial for manufacturing hard and soft capsules, serving as a plasma expander, and stabilizing vaccine formulations. Its growth is primarily fueled by the increasing worldwide incidence of chronic diseases and an expanding elderly population, both of which necessitate effective oral drug delivery systems to boost patient compliance and bioavailability. The material's exceptional functional attributes, such as superior film-forming capabilities and biocompatibility, further solidify its indispensable role in clinical applications. However, this growth is somewhat constrained by the inherent volatility of raw material costs. Notably, in 2025, the health and nutrition sector was identified as the predominant application area, with 54% of surveyed industry professionals operating within this segment, highlighting the critical reliance of both pharmaceutical and nutraceutical industries on this versatile excipient.
Market Driver
A key driver for the pharmaceutical gelatin market is the escalating demand for softgel and hard capsule delivery systems, which significantly enhance patient compliance by effectively masking taste and facilitating ease of swallowing. Gelatin is fundamental to these dosage forms, providing essential mechanical strength and dissolution properties crucial for securely encapsulating active pharmaceutical ingredients (APIs). This robust demand is reflected in financial reports, such as Nitta Gelatin India Limited's October 2025 statement, which cited a revenue increase to 141.93 crore INR, largely attributable to its pharmaceutical excipient lines. Concurrently, the rapid expansion of the nutraceutical and dietary supplement industry further propels market growth, driven by consumers' growing preference for preventative health solutions. Manufacturers are increasingly adopting pharmaceutical-grade gelatin for fortified functional foods and gummy supplements, which require precise textural and stability characteristics. This trend is underscored by rising supplement usage, like magnesium's increase to 23% among all supplement users, as reported by the Council for Responsible Nutrition in October 2024. Major producers, such as Nitta Gelatin Inc. with net sales of 18,499 million JPY for the six months ending September 2025, are sustaining substantial turnover, indicating gelatin's vital role across both clinical and wellness sectors.
Market Challenge
The significant volatility in raw material costs represents a critical challenge for the global pharmaceutical gelatin market, largely due to its heavy reliance on livestock by-products. As a derivative of the meat processing industry, pharmaceutical gelatin is susceptible to various external pressures, including sanitary regulations, animal disease outbreaks, and fluctuations in livestock populations. This dependency creates a fragile supply chain, often leading to sudden price escalations and significant procurement risks for pharmaceutical manufacturers, complicating cost management for essential drug delivery systems and deterring long-term investments in gelatin-based formulations. This instability in raw material supply directly impedes market scalability by limiting the availability of pharmaceutical-grade excipients needed to meet increasing demand. The issue is compounded by a contraction in livestock numbers in key regions, such as the estimated decline in European porcine production to approximately 218 million heads in 2024, according to Gelatine Manufacturers of Europe (GME). Such supply constraints force manufacturers to operate in a high-cost environment, thereby slowing the broader adoption of gelatin in mass-market pharmaceutical applications, despite its inherent functional advantages.
Market Trends
The market is undergoing a significant transformation with the expansion into regenerative medicine and hemostatic applications, positioning pharmaceutical gelatin as a cornerstone biomaterial for advanced clinical devices. Manufacturers are actively re-engineering gelatin's physicochemical properties to develop innovative solutions like flowable hemostats, wound healing scaffolds, and bio-inks that mimic the extracellular matrix, moving beyond its traditional role in encapsulation. This strategic shift towards high-value biomedical solutions is supported by substantial capital allocation from leading industry players who are diversifying their portfolios, exemplified by Darling Ingredients' global ingredients business achieving an EBITDA of $248 million in Q3 2025, enabling investments in next-generation medical devices. Additionally, the increasing commercialization of marine-sourced pharmaceutical gelatin is accelerating in response to a growing global demand for non-mammalian excipients, which align with strict Halal, Kosher, and pescatarian dietary requirements. This trend prompts producers to diversify their raw material supply chains beyond bovine and porcine sources to include cold-water fish skins, which offer comparable functional performance while circumventing regulatory hurdles associated with animal diseases. The commercial viability and profitability of adapting production portfolios to these evolving ethno-religious market needs are highlighted by Nitta Gelatin India Limited's reported profit before tax of 109.68 crore INR in its Annual Report 2024-25.
Key Market Players
* Gelita AG
* Trobas Pharmaceutical gelatine B.V
* Rousselot SAS
* Gelatines Weishardt SAS
* Sterling Biotec Ltd.
* Catalent, Inc
* Nitta Pharmaceutical Gelatin India Limited
* Aspire Pharmaceuticals
* Gelco International
* Lapi Gelatine S.p.a
Report Scope
In this report, the Global Pharmaceutical Gelatin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Pharmaceutical Gelatin Market, By Type
* Type A
* Type B
# Pharmaceutical Gelatin Market, By Source
* Porcine
* Bovine Skin
* Bovine Bone
* Fish
* Poultry
# Pharmaceutical Gelatin Market, By Function
* Stabilizing
* Thickening
* Gelling
* Others
# Pharmaceutical Gelatin Market, By End User
* Hard Capsule
* Soft Capsule
* Tablet
* Absorbable Hemostat
* Others
# Pharmaceutical Gelatin Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Gelatin Market.
Available Customizations:
Global Pharmaceutical Gelatin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Pharmaceutical Gelatin Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Type A, Type B)
5.2.2. By Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry)
5.2.3. By Function (Stabilizing, Thickening, Gelling, Others)
5.2.4. By End User (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat, Others)
5.2.5. By Region
5.2.6. By Company (2025)
5.3. Market Map
6. North America Pharmaceutical Gelatin Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Source
6.2.3. By Function
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Pharmaceutical Gelatin Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Source
6.3.1.2.3. By Function
6.3.1.2.4. By End User
6.3.2. Canada Pharmaceutical Gelatin Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Source
6.3.2.2.3. By Function
6.3.2.2.4. By End User
6.3.3. Mexico Pharmaceutical Gelatin Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Source
6.3.3.2.3. By Function
6.3.3.2.4. By End User
7. Europe Pharmaceutical Gelatin Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Source
7.2.3. By Function
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Pharmaceutical Gelatin Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Source
7.3.1.2.3. By Function
7.3.1.2.4. By End User
7.3.2. France Pharmaceutical Gelatin Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Source
7.3.2.2.3. By Function
7.3.2.2.4. By End User
7.3.3. United Kingdom Pharmaceutical Gelatin Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Source
7.3.3.2.3. By Function
7.3.3.2.4. By End User
7.3.4. Italy Pharmaceutical Gelatin Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Source
7.3.4.2.3. By Function
7.3.4.2.4. By End User
7.3.5. Spain Pharmaceutical Gelatin Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Source
7.3.5.2.3. By Function
7.3.5.2.4. By End User
8. Asia Pacific Pharmaceutical Gelatin Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Source
8.2.3. By Function
8.2.4. By End User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Pharmaceutical Gelatin Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Source
8.3.1.2.3. By Function
8.3.1.2.4. By End User
8.3.2. India Pharmaceutical Gelatin Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Source
8.3.2.2.3. By Function
8.3.2.2.4. By End User
8.3.3. Japan Pharmaceutical Gelatin Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Source
8.3.3.2.3. By Function
8.3.3.2.4. By End User
8.3.4. South Korea Pharmaceutical Gelatin Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Source
8.3.4.2.3. By Function
8.3.4.2.4. By End User
8.3.5. Australia Pharmaceutical Gelatin Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Source
8.3.5.2.3. By Function
8.3.5.2.4. By End User
9. Middle East & Africa Pharmaceutical Gelatin Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Source
9.2.3. By Function
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Pharmaceutical Gelatin Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Source
9.3.1.2.3. By Function
9.3.1.2.4. By End User
9.3.2. UAE Pharmaceutical Gelatin Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Source
9.3.2.2.3. By Function
9.3.2.2.4. By End User
9.3.3. South Africa Pharmaceutical Gelatin Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Source
9.3.3.2.3. By Function
9.3.3.2.4. By End User
10. South America Pharmaceutical Gelatin Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Source
10.2.3. By Function
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Pharmaceutical Gelatin Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Source
10.3.1.2.3. By Function
10.3.1.2.4. By End User
10.3.2. Colombia Pharmaceutical Gelatin Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Source
10.3.2.2.3. By Function
10.3.2.2.4. By End User
10.3.3. Argentina Pharmaceutical Gelatin Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Source
10.3.3.2.3. By Function
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Pharmaceutical Gelatin Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Gelita AG
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Trobas Pharmaceutical gelatine B.V
15.3. Rousselot SAS
15.4. Gelatines Weishardt SAS
15.5. Sterling Biotec Ltd.
15.6. Catalent, Inc
15.7. Nitta Pharmaceutical Gelatin India Limited
15.8. Aspire Pharmaceuticals
15.9. Gelco International
15.10. Lapi Gelatine S.p.a
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們